As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
As far the current severe coronavirus disease 2019 (COVID-19), respiratory disease is still the biggest threat to human health. In addition, infectious respiratory diseases are particularly prominent. In addition to killing and clearing the infection pathogen directly, regulating the immune responses against the pathogens is also an important therapeutic modality. Sirtuins belong to NAD+-dependent class III histone deacetylases. Among 7 types of sirtuins, silent information regulator type-1 (SIRT1) played a multitasking role in modulating a wide range of physiological processes, including oxidative stress, inflammation, cell apoptosis, autophagy, antibacterial and antiviral functions. It showed a critical effect in regulating immune responses by deacetylation modification, especially through high-mobility group box 1 (HMGB1), a core molecule regulating the immune system. SIRT1 was associated with many respiratory diseases, including COVID-19 infection, bacterial pneumonia, tuberculosis, and so on. Here, we reviewed the latest research progress regarding the effects of SIRT1 on immune system in respiratory diseases. First, the structure and catalytic characteristics of SIRT1 were introduced. Next, the roles of SIRT1, and the mechanisms underlying the immune regulatory effect through HMGB1, as well as the specific activators/inhibitors of SIRT1, were elaborated. Finally, the multitasking roles of SIRT1 in several respiratory diseases were discussed separately. Taken together, this review implied that SIRT1 could serve as a promising specific therapeutic target for the treatment of respiratory diseases.
Abstract
As far the current severe coronavirus disease 2019 (COVID-19), respiratory disease is still the biggest threat to human health. In addition, infectious respiratory diseases are particularly prominent. In addition to killing and clearing the infection pathogen directly, regulating the immune responses against the pathogens is also an important therapeutic modality. Sirtuins belong to NAD+-dependent class III histone deacetylases. Among 7 types of sirtuins, silent information regulator type-1 (SIRT1) played a multitasking role in modulating a wide range of physiological processes, including oxidative stress, inflammation, cell apoptosis, autophagy, antibacterial and antiviral functions. It showed a critical effect in regulating immune responses by deacetylation modification, especially through high-mobility group box 1 (HMGB1), a core molecule regulating the immune system. SIRT1 was associated with many respiratory diseases, including COVID-19 infection, bacterial pneumonia, tuberculosis, and so on. Here, we reviewed the latest research progress regarding the effects of SIRT1 on immune system in respiratory diseases. First, the structure and catalytic characteristics of SIRT1 were introduced. Next, the roles of SIRT1, and the mechanisms underlying the immune regulatory effect through HMGB1, as well as the specific activators/inhibitors of SIRT1, were elaborated. Finally, the multitasking roles of SIRT1 in several respiratory diseases were discussed separately. Taken together, this review implied that SIRT1 could serve as a promising specific therapeutic target for the treatment of respiratory diseases.
참고문헌 (136)
- Wu J, "Revisiting the immune balance theory : a neurological insight into the epidemic of COVID-19and its alike", Front Neurol, 11, pp.566680~ (2020)
- Vyas SP, "Striking the right immunological balance prevents progression of tuberculosis", Inflamm Res, 66, pp.1031~1056 (2017)
- Cigana C, "Dampening host sensing and avoiding recognition in Pseudomonas aeruginosa pneumonia", J Biomed Biotechnol, 2011, pp.852513~ (2011)
- Guan R, "Hydrogen sulfide attenuates mitochondrial dysfunction-induced cellular senescence and apoptosis in alveolar epithelial cells by upregulating sirtuin 1", Aging(Albany NY), 11, pp.11844~11864 (2019)
- Li WF, "Genistein ameliorates ischemia", reperfusion-induced renal injury in a SIRT1-dependent manner, 2017, pp.9, 403~
- Chen C, "SIRT1 and aging related signaling pathways", Mech Ageing Dev, 187, pp.111215~ (2020)
- D’Onofrio N, "SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection", Antioxid Redox Signal, 28, pp.711~732 (2018)
- Almeida M, "Sirtuins and FoxOs in osteoporosis and osteoarthritis", Bone, 121, pp.284~292 (2019)
- Jiao F, "The beneficial roles of SIRT1 in neuroinflammation-related diseases", Oxid Med Cell Longev, 2020, pp.6782872~ (2020)
- Zhang W, "Sirt1 inhibits oxidative stress in vascular endothelial cells", Oxid Med Cell Longev, 2017, pp.7543973~ (2017)
- Lu G, "Role and possible mechanisms of Sirt1 in depression", Oxid Med Cell Longev, 2018, pp.8596903~ (2018)
- Yang Q, "Will sirtuins be promising therapeutic targets for TBI and associated neurodegenerative diseases?", Front Neurosci, 14, pp.791~ (2020)
- Suenkel B, "Recombinant preparation, biochemical analysis, and structure determination of sirtuin family histone", protein deacylases, 2016, pp.573, 183~208
- Davenport AM, "Structural and functional analysis of human SIRT1", J Mol Biol, 426, pp.526~541 (2014)
- Lu CL, "Sirtuin-1 and its relevance in vascular calcification", Int J Mol Sci, 21, pp.1593~ (2020)
- Nikas IP, "The role of nicotinamide in cancer chemoprevention and therapy", Biomolecules, 10, pp.477~ (2020)
- Kane AE, "Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases", Circ Res, 123, pp.868~885 (2018)
- Alqarni MH, "The pleiotropic function of human sirtuins as modulators of metabolic pathways and viral infections", Cells, 10, pp.460~ (2021)
- Carafa V, "Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype", Front Pharmacol, 10, pp.38~ (2019)
- Farghali H, "SIRT1 modulators in experimentally induced liver injury", Oxid Med Cell Longev, 2019, pp.8765954~ (2019)
- Zhang Y, "WWP2 regulates SIRT1-STAT3 acetylation and phosphorylation involved in hypertensive angiopathy", J Cell Mol Med, 24, pp.9041~9054 (2020)
- 이해리, "Highlighted STAT3 as a potential drug target for cancer therapy", BMB Reports, 52(7), pp.415~423 (2019), 생화학분자생물학회[DOI]
- Zhang S, "SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3", MMP-13 signaling, 2019, pp.234, 15395~15406
- Hillmer EJ, "STAT3 signaling in immunity", Cytokine Growth Factor Rev, 31, pp.1~15 (2016)
- Chen J, "Protective effects of melatonin on sepsis-induced liver injury and dysregulation of gluconeogenesis in rats through activating SIRT1", STAT3 pathway, 2019, pp.117, 109150~
- Xu G, "MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1", JAK, Exp Cell Res, pp.2018, 362[DOI]
- Rius-Pérez S, "PGC-1α, inflammation, and oxidative stress : an integrative view in metabolism", Oxid Med Cell Longev, 2020, pp.1452696~ (2020)
- Liu Y, "Trpv4 regulates Nlrp3 inflammasome via SIRT1", PGC-1α pathway in a cuprizone-induced mouse model of demyelination, 2021, pp.337, 113593~
- Xue H, "Salidroside stimulates the Sirt1", PGC-1α axis and ameliorates diabetic nephropathy in mice, 2019, pp.54, 240~247
- Liang D, "SIRT1", PGC-1 pathway activation triggers autophagy, Biochimie, pp.2020, 170[DOI]
- Waldman M, "Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’", Cardiovasc Diabetol, 17, pp.111~ (2018)
- Wang XL, "The effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease", Molecules, 22, pp.1529~ (2017)
- Wang S, "Function of hesperidin alleviating inflammation and oxidative stress responses in COPD mice might be related to SIRT1", PGC-1α, J Recept Signal Transduct Res, pp.2020, 40[DOI]
- Brown AK, "Regulation of FOXO factors in mammalian cells", Curr Top Dev Biol, 127, pp.165~192 (2018)
- Deng Y, "FOXOs in cancer immunity : knowns and unknowns", Semin Cancer Biol, 50, pp.53~64 (2018)
- Zhang M, "miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation", Cell Death Dis, 8, pp.e3088~ (2017)
- Wu Q, "Effect of autophagy regulated by Sirt1", FoxO1 pathway on the release of factors promoting thrombosis from vascular endothelial cells, 2019, pp.20, 4132~
- Ren BC, "Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways", J Cell Mol Med, 24, pp.12355~12367 (2020)
- Roy S, "Crosstalk of PD-1 signaling with the SIRT1", FOXO-1 axis during the progression of visceral leishmaniasis, 2019, pp.132, jcs226274~
- Taka C, "SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients", Int J Chron Obstruct Pulmon Dis, 12, pp.3237~3244 (2017)
- Korbecki J, "Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors", Inflamm Res, 68, pp.443~458 (2019)
- Wang J, "SIRT1 prevents hyperuricemia via the PGC-1α", PPARγ-ABCG2 pathway, 2016, pp.53, 443~452
- Wang J, "Sirt1 inhibits gouty arthritis via activating PPARγ", Clin Rheumatol, 38, pp.3235~3242 (2019)
- Legutko A, "Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferatoractivated receptor-γ activity in dendritic cells", J Immunol, 187, pp.4517~4529 (2011)
- Andersson U, "Extracellular HMGB1 as a therapeutic target in inflammatory diseases", Expert Opin Ther Targets, 22, pp.263~277 (2018)
- Xu S, "Evidence for SIRT1 mediated HMGB1 release from kidney cells in the early stages of hemorrhagic shock", Front Physiol, 10, pp.854~ (2019)
- Zhao S, "Dexamethasone inhibits NF-κBp65 and HMGB1 expression in the pancreas of rats with severe acute pancreatitis", Mol Med Rep, 18, pp.5345~5352 (2018)
- de Gregorio E, "Relevance of SIRT1-NF-κB axis as therapeutic target to ameliorate inflammation in liver disease", Int J Mol Sci, 21, pp.3858~ (2020)
- Chen X, "Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1", NF-κB pathway following experimental traumatic brain injury, 2018, pp.15, 116~
- Meng L, "The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4", NF-κB and PI3K, mTOR pathways, pp.Mol Immunol, 2018[DOI]
- Chi JH, "Isoliquiritigenin inhibits TNF-α-induced release of high-mobility group box 1 through activation of HDAC in human intestinal epithelial HT-29 cells", Eur J Pharmacol, 796, pp.101~109 (2017)
- Wang J, "HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE", NF-κB signaling pathways, 2020, pp.45, 61~80
- Guo LT, "Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K", AKT, J Neuroinflammation, pp.2019, 16[DOI]
- Xu X, "Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1", TLR4, TNFR1, pp.NF-κB pathways, Br J Pharmacol[DOI]
- Gu C, "Therapeutic effects of SRT2104 on lung injury in rats with emphysema via reduction of type II alveolar epithelial cell senescence", COPD, 17, pp.444~451 (2020)
- Zhang YZ, "Effects of SIRT1", Akt pathway on chronic inflammatory response and lung function in patients with asthma, 2019, pp.23, 4948~4953
- Wu Y, "Suppression of sirtuin 1 alleviates airway inflammation through mTORmediated autophagy", Mol Med Rep, 22, pp.2219~2226 (2020)
- Yang H, "Sirtuin inhibits M. tuberculosis-induced apoptosis in macrophage through glycogen synthase kinase-3β", Arch Biochem Biophys, 694, pp.108612~ (2020)
- Ji K, "Regulation of apoptosis and radiation sensitization in lung cancer cells via the Sirt1", NF-κB, Cell Physiol Biochem, pp.2018, 48[DOI]
- Chen M, "Bergenin-activated SIRT1 inhibits TNF-α-induced proinflammatory response by blocking the NF-κB signaling pathway", Pulm Pharmacol Ther, 62, pp.101921~ (2020)
- Colley T, "Defective sirtuin-1 increases IL-4 expression through acetylation of GATA-3 in patients with severe asthma", J Allergy Clin Immunol, 137, pp.1595~1597 (2016)
- Ma K, "Sirtuins as novel targets in the pathogenesis of airway inflammation in bronchial asthma", Eur J Pharmacol, 865, pp.172670~ (2019)
- Yang H, "Role of Sirt1 in innate immune mechanisms against Mycobacterium tuberculosis via the inhibition of TAK1 activation", Arch Biochem Biophys, 667, pp.49~58 (2019)
- Annamanedi M, "Celecoxib enhances the efficacy of low-dose antibiotic treatment against polymicrobial sepsis in mice and clinical isolates of ESKAPE pathogens", Front Microbiol, 8, pp.805~ (2017)
- Wang J, "Resveratrol, an activator of SIRT1, induces protective autophagy in nonsmall-cell lung cancer via inhibiting Akt", mTOR and activating p38-MAPK, 2018, pp.11, 7777~7786
- Sun X, "Nucleosides isolated from Ophiocordyceps sinensis inhibit cigarette smoke extract-induced inflammation via the SIRT1-nuclear factor-κB", p65 pathway in RAW264. 7 macrophages and in COPD mice, 2018, pp.13, 2821~2832
- Li X, "SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling", Onco Targets Ther, 11, pp.1157~1171 (2018)
- Zhan Y, "Silent information regulator type-1 mediates amelioration of inflammatory response and oxidative stress in lipopolysaccharide-induced acute respiratory distress syndrome", J Biochem, 169, pp.613~620 (2021)
- Yang X, "The role and mechanism of SIRT1 in resveratrol-regulated osteoblast autophagy in osteoporosis rats", Sci Rep, 9, pp.18424~ (2019)
- Saeedi-Boroujeni A, "Anti-inflammatory potential of Quercetin in COVID-19treatment", J Inflamm(Lond), 18, pp.3~ (2021)
- Zhao S, "Sirtuin 1 activated by SRT1460 protects against myocardial ischemia", reperfusion injury, 2021, pp.78, 271~281
- Ren Y, "The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress", Int J Mol Med, 39, pp.1317~1324 (2017)
- Zheng Y, "Berberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages", Aging(Albany NY), 13, pp.7096~7119 (2021)
- Wang C, "Metformin mitigates cartilage degradation by activating AMPK", SIRT1-mediated autophagy in a mouse osteoarthritis model, 2020, pp.11, 1114~
- Zhang WX, "Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice", Life Sci, 217, pp.8~15 (2019)
- Sun T, "SRT2183 impairs ovarian cancer by facilitating autophagy", Aging(Albany NY), 12, pp.24208~24218 (2020)
- Wang T, "EX527, a Sirt-1 inhibitor, induces apoptosis in glioma via activating the p53signaling pathway", Anticancer Drugs, 31, pp.19~26 (2020)
- Marx C, "The sirtuin 1", 2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factordependent cell death in a p53 null Ewing’s sarcoma cell line, 2018, pp.36, 396~406
- He M, "SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells", J Pathol, 242, pp.309~321 (2017)
- Lu B, "Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells", Oncol Lett, 21, pp.306~ (2021)
- Ye Q, "Sirtinol regulates the balance of Th17", Treg to prevent allograft rejection, 2017, pp.7, 55~
- Mu N, "Inhibition of SIRT1", 2 upregulates HSPA5acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells, 2019, pp.24, 798~811
- Park JA, "Splitomicin, a SIRT1 inhibitor, enhances hematopoietic differentiation of mouse embryonic stem cells", Int J Stem Cells, 12, pp.21~30 (2019)
- Pan S, "Nicotinamide increases the sensitivity of chronic myeloid leukemia cells to doxorubicin via the inhibition of SIRT1", J Cell Biochem, 121, pp.574~586 (2020)
- Chung JY, "Resveratrol modulates the gut-brain axis : focus on glucagon-like peptide-1, 5-HT, and gut microbiota", Front Aging Neurosci, 12, pp.588044~ (2020)
- Qin H, "Resveratrol attenuates radiation enteritis through the SIRT1", FOXO3a and PI3K, Biochem Biophys Res Commun, pp.2021, 554[DOI]
- Yang D, "Quercetin : its main pharmacological activity and potential application in clinical medicine", Oxid Med Cell Longev, 2020, pp.8825387~ (2020)
- Hu T, "Quercetin ameliorates diabetic encephalopathy through SIRT1", ER stress pathway in db, Aging(Albany NY), pp.2020, 12[DOI]
- Broussy S, "Biochemical mechanism and biological effects of the inhibition of silent information regulator 1(SIRT1)by EX-527(SEN0014196 or selisistat)", J Enzyme Inhib Med Chem, 35, pp.1124~1136 (2020)
- Chen G, "Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis", Oncogene, 36, pp.6863~6872 (2017)
- Moschos MM, "The role of histone deacetylase inhibitors in uveal melanoma : current evidence", Anticancer Res, 38, pp.3817~3824 (2018)
- Lee BB, "Metformin and tenovin-6synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells", J Cell Mol Med, 23, pp.2872~2889 (2019)
- Hu J, "Sirtuin inhibitors as anticancer agents", Future Med Chem, 6, pp.945~966 (2014)
- Chimento A, "SIRT1 is involved in adrenocortical cancer growth and motility", J Cell Mol Med, 25, pp.3856~3869 (2021)
- Kratz EM, "Sirtuins as important factors in pathological states and the role of their molecular activity modulators", Int J Mol Sci, 22, pp.630~ (2021)
- Guo Q, "Inhibition of SIRT1promotes taste bud stem cell survival and mitigates radiation-induced oral mucositis in mice", Am J Transl Res, 11, pp.4789~4799 (2019)
- He M, "Disease burden from COVID-19symptoms among inpatients at the temporary military hospitals in Wuhan : a retrospective multicentre cross-sectional study", BMJ Open, 11, pp.e048822~ (2021)
- Kadkhoda K, "COVID-19 : an immunopathological view", MSphere, 5, pp.e00344-20~ (2020)
- Jit BP, "An immune epigenetic insight to COVID-19infection", Epigenomics, 13, pp.465~480 (2021)
- Miller R, "COVID-19 : NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity", Med Hypotheses, 144, pp.110044~ (2020)
- Bordoni V, "The unbalanced p53", SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients, 2021, pp.105, 49~53
- DiNicolantonio JJ, "Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections", Open Heart, 8, pp.e001568~ (2021)
- Huarachi Olivera RE, "Coronavirus disease(COVID-19)and sirtuins", Rev Fac Cien Med Univ Nac Cordoba, 77, pp.117~125 (2020)
- Samadder S, "Immunopathological changes in SARS-CoV-2 critical and non-critical pneumonia patients : a systematic review to determine the cause of co-infection", Front Public Health, 8, pp.544993~ (2021)
- Ferri M, "Antimicrobial resistance : a global emerging threat to public health systems", Crit Rev Food Sci Nutr, 57, pp.2857~2876 (2017)
- Dunne EM, "Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children : a cross-sectional study", PLoS One, 13, pp.e0195098~ (2018)
- Elesela S, "Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells", PLoS Pathog, 16, pp.e1008319~ (2020)
- Singh V, "Role of silent information regulator 1(SIRT1)in regulating oxidative stress and inflammation", Inflammation, 43, pp.1589~1598 (2020)
- Opal SM, "Pharmacological SIRT1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis", Shock, 45, pp.411~418 (2016)
- Lin L, "Role of SIRT1 in Streptococcus pneumoniae-induced human β-defensin-2 and interleukin-8 expression in A549 cell", Mol Cell Biochem, 394, pp.199~208 (2014)
- Li QR, "Mechanism of chlorogenic acid in alveolar macrophage polarization in Klebsiella pneumoniae-induced pneumonia", J Leukoc Biol (2021)[DOI]
- Yang H, "Sirt1 activation negatively regulates overt apoptosis in Mtb-infected macrophage through Bax", Int Immunopharmacol, 91, pp.107283~ (2021)
- Stek C, "The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy", Front Microbiol, 9, pp.2603~ (2018)
- Kim SY, "ESRRA(estrogen-related receptor α)is a key coordinator of transcriptional and post-translational activation of autophagy to promote innate host defense", Autophagy, 14, pp.152~168 (2018)
- Cheng CY, "Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis", Sci Immunol, 2, pp.eaaj1789~ (2017)
- Fernández-Villar A, "Reliability and usefulness of spirometry performed during admission for COPD exacerbation", PLoS One, 13, pp.e0194983~ (2018)
- Wang Y, "Fengbaisan suppresses endoplasmic reticulum stress by upregulating SIRT1 expression to protect rats with chronic obstructive pulmonary diseases", Pharm Biol, 58, pp.878~885 (2020)
- Zhou X, "Expression of diaphragmatic myostatin and correlation with apoptosis in rats with chronic obstructive pulmonary disease", Exp Ther Med, 15, pp.2295~2300 (2018)
- Zhang L, "SIRT1 attenuates endoplasmic reticulum stress and apoptosis in rat models of COPD", Growth Factors, 38, pp.94~104 (2020)
- Wang Y, "LINC00987 ameliorates COPD by regulating LPS-induced cell apoptosis, oxidative stress, inflammation and autophagy through Let-7b-5p", SIRT1 axis, 2020, pp.15, 3213~3225
- He B, "Melatonin protects against COPD by attenuating apoptosis and endoplasmic reticulum stress via upregulating SIRT1 expression in rats", Can J Physiol Pharmacol, 97, pp.386~391 (2019)
- Gu C, "LncRNA-mediated SIRT1", FoxO3a and SIRT1, Mol Med Rep, pp.2017, 15[DOI]
- Shin NR, "Role of melatonin as an SIRT1 enhancer in chronic obstructive pulmonary disease induced by cigarette smoke", J Cell Mol Med, 24, pp.1151~1156 (2020)
- Zhang Y, "Antagonistic peptides that specifically bind to the first and second extracellular loops of CCR5 and Anti-IL-23p19 antibody reduce airway inflammation by suppressing the IL-23", Th17 signaling pathway, 2020, pp.2020, 1719467~
- Xinliu Lin, "Important Role of Immunological Responses to Environmental Exposure in the Development of Allergic Asthma", Allergy, Asthma & Immunology Research, 12(6), pp.934~948 (2020), 대한천식알레르기학회[DOI]
- Tang L, "Suppression of Sirtuin-1 increases IL-6expression by activation of the Akt pathway during allergic asthma", Cell Physiol Biochem, 43, pp.1950~1960 (2017)
- Zhang H, "miR-221 participates in the airway epithelial cells injury in asthma via targeting SIRT1", Exp Lung Res, 44, pp.272~279 (2018)
- Lin H, "Circular RNA has Circ 001372-reduced inflammation in ovalbumin-induced asthma through Sirt1", NFAT5 signaling pathway by miRNA-128-3p, 2022, ~
- Liu Y, "Anthocyanins inhibit airway inflammation by downregulating the NF-κB pathway via the miR-138-5p", SIRT1 axis in asthmatic mice, 2022, pp.183, 539~551
- Lai T, "Myeloid-specific SIRT1deletion exacerbates airway inflammatory response in a mouse model of allergic asthma", Aging(Albany NY), 13, pp.15479~15490 (2021)
- Huppert LA, "Pathogenesis of acute respiratory distress syndrome", Semin Respir Crit Care Med, 40, pp.31~39 (2019)
- Lupu L, "Inflammation, thrombosis, and destruction : the three-headed cerberus of trauma-and SARS-CoV-2-induced ARDS", Front Immunol, 11, pp.584514~ (2020)
- Banavasi H, "Management of ARDS – What works and what does not", Am J Med Sci, 362, pp.13~23 (2021)
- Liu Y, "Acute downregulation of miR-199a attenuates sepsis-induced acute lung injury by targeting SIRT1", Am J Physiol Cell Physiol, 314, pp.C449~ (2018)
- Ma L, "3, 5, 4′-Tri-O-acetylresveratrol attenuates lipopolysaccharide-induced acute respiratory distress syndrome via MAPK", SIRT1 pathway, 2015, pp.2015, 143074~
- Yu LL, "Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression", Eur Rev Med Pharmacol Sci, 22, pp.5355~5363 (2018)
